Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Despite its initial fumble with Google Glass, there are a few reasons it may be able to avoid another “glassholes” situation.
The company’s ad overhaul has largely worked in its favor based on its recent earnings report
The famed strategist believes the global economy has entered a new phase — and it could get quite a bit rocky.